Atlas Trials

FUDR/Oxaliplatin HAI Plus Irinotecan vs. FOLFOXIRI Chemotherapy in Treating Initially Unresectable CRCLM

Clinical trial NCT03678428 · TERMINATED

Trial details

NCT number
NCT03678428
Sponsor
Sun Yat-sen University
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Metastatic Colorectal CancerLiver Metastases
Start date
2021-12-31
Primary completion
2022-10-31
Enrollment
92

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.